Total: 5 |
|
PMID (PMCID) | ||
---|---|---|
8312669 |
MIXED_SAMPLE | Middle Aged |
Myelodysplastic syndrome associated with myelofibrosis, a report of 3 cases. | ||
Kamei S, Shinohara K, Oeda E. Intern Med. 1993;32(8):668-71. |
||
Three cases of primary myelodysplastic syndrome (MDS) associated with myelofibrosis were initially diagnosed as refractory anemia by the presence of bicytopenia or pancytopenia and having normo- or hypercellular marrow with dysplastic features. | ||
1774954 |
MIXED_SAMPLE | Middle Aged |
Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders. | ||
Rege-Cambrin G, Speleman F, Kerim S, Scaravaglio P, Carozzi F, Dal Cin P, Michaux JL, Offner F, Saglio G, Van den Berghe H. Leukemia. 1991;5(12):1059-63. |
||
Two patients had polycythemia vera in transformation (erythroleukemia in one patient and refractory anemia in the second), whereas the third patient had myelofibrosis which later evolved into acute myelomonocytic leukemia. | ||
1942532 |
MALE | |
[Myelodysplasia predominantly involving in megakaryocytic lineage successfully treated with low-dose Ara-C]. | ||
Tsushita K, Hotta T, Inoue C, Ichikawa A, Murate T, Saito H. Rinsho Ketsueki. 1991;32(8):897-902. |
||
Therefore he was diagnosed as refractory anemia (RA) or MDS with myelofibrosis and treated with low dose Ara-C regimen. | ||
3279751 |
MALE | Middle Aged |
Myelodysplastic syndrome with acquired hemoglobin H disease. Evolution through megakaryoblastic transformation into myelofibrosis. | ||
Abbondanzo SL, Anagnou NP, Sacher RA. Am J Clin Pathol. 1988;89(3):401-6. |
||
Although idiopathic myelofibrosis also has been described as a setting in which this thalassemic syndrome occurs, the present case is unusual in that the myelofibrosis was preceded by refractory anemia with leukemic transformation. | ||
3060251 |
MIXED_SAMPLE | Child |
Translocation t(1;7) revisited. Report of three further cases and review. | ||
Willem P, Pinto M, Bernstein R. Cancer Genet Cytogenet. 1988;36(1):45-54. |
||
Three white patients, two with myelofibrosis and one with refractory anemia, presented with a t(1;7). |